Patent · US Expired

Pharmaceutical aqueous formulations containing a sparingly soluble pharmaceutical active compound with a solubilizing polymeric agent

US5576012A · kind A · utility

36Cited by
2References
21Claims
0Family size

Inventors

Key dates

Filing dateAug 10, 1993
Grant dateNov 19, 1996
Priority date
Expiry dateAug 10, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08F20/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutical formulations which comprise at least one pharmaceutical active compound in combination with a polymer of the general formula I or I', in particular for intravenous administration, ##STR1## in which R.sub.1, R.sub.2, R.sub.5 and R.sub.6 are identical or different and represent hydrogen and a methyl or ethyl group, PA1 Q represents a valency, oxygen or an ester or amide bridge and Q' denotes hydrogen if Q represents a valency or oxygen, and is a hydroxyl or amino group if Q represents an ester or amide bridge, PA1 x is an integer from 3 to 50, preferably 5 to 40, if Q is a valency or oxygen, and an integer from 3 to 1000, preferably 50 to 100, if Q is an ester or amide function, G.sub.1 and G.sub.2 are a valency, oxygen or an ester or amide group, it being possible for the two groups to be identical or different, n is an integer from 4 to 44, preferably 12 to 16, PA1 y is an integer from 2 to 50, preferably 10 to 40, and R.sub.3 is hydrogen or a lower alkyl having 1-6 C atoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.